Elekta (OTCMKTS:EKTAY) Sees Unusually-High Trading Volume – What’s Next?

Elekta AB (OTCMKTS:EKTAY) saw unusually-high trading volume on Monday . Approximately 4,966 shares changed hands during trading, an increase of 107% from the previous session’s volume of 2,403 shares.The stock last traded at $4.9550 and had previously closed at $5.0250.

Analyst Ratings Changes

Separately, Zacks Research cut Elekta from a “hold” rating to a “strong sell” rating in a research note on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.

Elekta Stock Performance

The stock has a market capitalization of $1.82 billion, a PE ratio of -30.88 and a beta of 1.00. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.73 and a current ratio of 0.95. The firm’s 50 day moving average is $5.89 and its two-hundred day moving average is $6.06.

Elekta (OTCMKTS:EKTAY) last issued its quarterly earnings results on Thursday, May 28th. The company reported $0.06 EPS for the quarter. The company had revenue of $521.00 million during the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 10.67%. As a group, research analysts predict that Elekta AB will post 0.43 earnings per share for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.